HomeBNTC • NASDAQ
Benitec Biopharma Inc
$5.13
Mar 28, 4:05:24 AM GMT-4 · USD · NASDAQ · Disclaimer
StockUS listed security
Previous close
$5.00
Day range
$5.08 - $5.27
Year range
$1.86 - $9.01
Market cap
13.30M USD
Avg Volume
23.88K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD)Dec 2023Y/Y change
Revenue
Operating expense
6.93M23.15%
Net income
-6.80M-25.63%
Net profit margin
Earnings per share
EBITDA
-6.91M-24.08%
Effective tax rate
Total assets
Total liabilities
(USD)Dec 2023Y/Y change
Cash and short-term investments
20.37M93.36%
Total assets
21.35M79.36%
Total liabilities
5.88M102.10%
Total equity
15.47M
Shares outstanding
2.59M
Price to book
0.84
Return on assets
-71.55%
Return on capital
-89.51%
Net change in cash
(USD)Dec 2023Y/Y change
Net income
-6.80M-25.63%
Cash from operations
-5.36M8.18%
Cash from investing
Cash from financing
39.00K
Net change in cash
-5.49M8.46%
Free cash flow
-2.83M27.03%
About
Benitec Biopharma Limited is an Australian biotechnology company founded in 1997. It is engaged in the development of gene-silencing therapies for the treatment of chronic and life-threatening diseases using DNA-directed RNA interference technology. The CSIRO has researched RNAi extensively, developing the small hairpin RNA concept employed in ddRNAi. Benitec Biopharma has an exclusive license to this ddRNAi technology in human therapeutic uses and research. Wikipedia
Founded
1997
Employees
17
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu